FluoSphera raises €1.2M Seed round
12 January 2026· Geneva, Switzerland· health, biotech, drug_discovery, ai, preclinical_testing, b2b, software_hardware
The funding will be used to scale commercial collaborations, grow its business development team, and expand its AI and automation capabilities for large-scale imaging analysis.
Investors
LeadSoulmates Ventures
Also participating
Swiss business angelIndieBio New York
About FluoSphera
Stage
Seed
Headquarters
Geneva, Switzerland
Founded
2021
Team Size
1–5
Sectors
healthbiotechdrug_discoveryaipreclinical_testingb2bsoftware_hardware